Mishcon de Reya recently advised drug discovery company Optibrium Limited on its multi-million-pound financing package from Shawbrook.
Optibrium specialises in software solutions for drug discovery, particularly in the field of small molecule design and optimisation and the company collaborates with a broad range of customer with its products being deployed by over 160 organisations worldwide, including leading global pharmaceutical companies.
The deal will allow the company to strengthen its offering for global pharmaceutical and biotech teams and boost the speed and efficiency of their drug discovery process.
Mishcon de Reya's Corporate Innovation and Venture Capital team was led by Erika McIntyre with support from Patrick Neall.